<SEC-DOCUMENT>0001193125-22-186684.txt : 20220701
<SEC-HEADER>0001193125-22-186684.hdr.sgml : 20220701
<ACCEPTANCE-DATETIME>20220701071430
ACCESSION NUMBER:		0001193125-22-186684
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20220701
FILED AS OF DATE:		20220701
DATE AS OF CHANGE:		20220701

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AEGON NV
		CENTRAL INDEX KEY:			0000769218
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10882
		FILM NUMBER:		221059606

	BUSINESS ADDRESS:	
		STREET 1:		AEGONPLEIN 50
		STREET 2:		PO BOX 85
		CITY:			THE HAGUE
		STATE:			P7
		ZIP:			2501 CB
		BUSINESS PHONE:		011-31-70-344-7308

	MAIL ADDRESS:	
		STREET 1:		AEGONPLEIN 50
		STREET 2:		PO BOX 85
		CITY:			THE HAGUE
		STATE:			P7
		ZIP:			2501 CB
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d353258d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Securities and Exchange Commission
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Report of
Foreign Issuer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Rule <FONT STYLE="white-space:nowrap">13a-16</FONT> or 15d/16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>July 2022 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Aegon N.V.
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Aegonplein 50 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2591 TV
THE HAGUE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Netherlands </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon&#146;s press release, dated July&nbsp;1, 2022, is included as appendix and incorporated herein by
reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Aegon N.V.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(Registrant)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: July&nbsp;1, 2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ J.O. van Klinken</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.O. van Klinken</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Executive Vice President and
General Counsel</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g353258dspp1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">The Hague &#150; July&nbsp;1, 2022 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon to repurchase shares to neutralize 2021 final dividend paid in shares </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Aegon will repurchase common shares for an amount of EUR 106&nbsp;million to neutralize the dilutive effect of the 2021 final dividend paid in shares.
These shares will be held as treasury shares and will be used to pay future stock dividends in shares. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders were given the opportunity to
choose between receiving the 2021 final dividend&nbsp;of EUR 0.09 per common share in cash or in shares. The stock dividend and the cash dividend&nbsp;are approximately equal in value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">58% of shareholders elected to receive the final dividend in shares. Those who elected stock&nbsp;dividend will receive one Aegon common share for every 47
common shares held. The stock&nbsp;fraction is based on Aegon&#146;s average share price as quoted on Euronext Amsterdam, using the&nbsp;high and low of each of the five trading days from June&nbsp;23 up to and including&nbsp;June 29, 2022. The
average share price calculated on this basis amounted to EUR 4.26. The dividend will be payable as of July&nbsp;6, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The repurchase of shares will
commence on July&nbsp;7, 2022 and is expected to be completed on or before September&nbsp;30, 2022. The transaction will amount to EUR 106&nbsp;million. Aegon has engaged a third party to execute the transactions on&nbsp;its behalf. The common
shares will be repurchased at a maximum of the average of the daily&nbsp;volume-weighted average prices during the repurchase period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This program is in
addition to the existing EUR 300&nbsp;million share buyback that was announced on March&nbsp;23, 2022, of which the second tranche will commence on July&nbsp;7, 2022. Weekly updates regarding all the share buyback transactions are available on
aegon.com. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Aegon </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon&#146;s roots go back more than 175
years &#150; to the first half of the nineteenth century. Since then, Aegon has grown into an international company, with businesses in the Americas, Europe and Asia. Today, Aegon is one of the world&#146;s leading financial services organizations,
providing life insurance, pensions and asset management. Aegon&#146;s purpose is to help people achieve a lifetime of financial security. More information on aegon.com. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Contacts</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Media relations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Investor relations</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dick Schiethart</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Jan Willem Weidema</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">+31(0) 70 344 8821</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+31(0) 70 344 8028</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">dick.schiethart@aegon.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">janwillem.weidema@aegon.com</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g353258dsp4.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">The Hague &#150; July&nbsp;1, 2022 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The statements contained in
this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target,
intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, could, is confident, will, and similar expressions as they relate to Aegon. These statements may contain information about financial
prospects, economic conditions and trends and involve risks and uncertainties. In addition, any statements that refer to sustainability, environmental and social targets, commitments, goals, efforts and expectations and other events or circumstances
that are partially dependent on future events are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation,
and expressly disclaims any duty, to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing.
Actual results may differ materially and adversely from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Unexpected delays, difficulties, and expenses in executing against our environmental, climate, diversity and
inclusion or other &#147;ESG&#148; targets, goals and commitments, and changes in laws or regulations affecting us, such as changes in data privacy, environmental, safety and health laws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in general economic and/or governmental conditions, particularly in the United States, the Netherlands
and the United Kingdom; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Civil unrest, <FONT STYLE="white-space:nowrap">(geo-)</FONT> political tensions, military action or other
instability in a country or geographic region; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the performance of financial markets, including emerging markets, such as with regard
to:&nbsp;&nbsp;&nbsp;&nbsp; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The frequency and severity of defaults by issuers in Aegon&#146;s fixed income investment portfolios;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting
decline in the value of equity and debt securities Aegon holds; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The effects of declining creditworthiness of certain public sector securities and the resulting decline in the
value of government exposure that Aegon holds; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the performance of Aegon&#146;s investment portfolio and decline in ratings of Aegon&#146;s
counterparties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lowering of one or more of Aegon&#146;s debt ratings issued by recognized rating organizations and the adverse
impact such action may have on Aegon&#146;s ability to raise capital and on its liquidity and financial condition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lowering of one or more of insurer financial strength ratings of Aegon&#146;s insurance subsidiaries and the
adverse impact such action may have on the written premium, policy retention, profitability and liquidity of its insurance subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The effect of the European Union&#146;s Solvency II requirements and other regulations in other jurisdictions
affecting the capital Aegon is required to maintain; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets
funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Catastrophic events, either manmade or by nature, including by way of example acts of God, acts of terrorism,
acts of war and pandemics, could result in material losses and significantly interrupt Aegon&#146;s business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The frequency and severity of insured loss events; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the
profitability of Aegon&#146;s insurance products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Aegon&#146;s projected results are highly sensitive to complex mathematical models of financial markets,
mortality, longevity, and other dynamic systems subject to shocks and unpredictable volatility. Should assumptions to these models later prove incorrect, or should errors in those models escape the controls in place to detect them, future
performance will vary from projected results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in customer behavior and public opinion in general related to, among other things, the type of products
Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Customer responsiveness to both new products and distribution channels; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As Aegon&#146;s operations support complex transactions and are highly dependent on the proper functioning of
information technology, operational risks such as system disruptions or failures, security or data privacy breaches, cyberattacks, human error, failure to safeguard personally identifiable information, changes in operational practices or inadequate
controls including with respect to third parties with which we do business may disrupt Aegon&#146;s business, damage its reputation and adversely affect its results of operations, financial condition and cash flows; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items,
including Aegon&#146;s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Aegon&#146;s failure to achieve anticipated levels of earnings or operational efficiencies, as well as other
management initiatives related to cost savings, Cash Capital at Holding, gross financial leverage and free cash flow; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the policies of central banks and/or governments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does
business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for
Aegon&#146;s products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consequences of an actual or potential <FONT STYLE="white-space:nowrap">break-up</FONT> of the European monetary
union in whole or in part, or the exit of the United Kingdom from the European Union and potential consequences if other European Union countries leave the European Union; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in laws and regulations, particularly those affecting Aegon&#146;s operations&#146; ability to hire and
retain key personnel, taxation of Aegon companies, the products Aegon sells, and the attractiveness of certain products to its consumers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which
Aegon operates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and
the International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the
designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer <FONT STYLE="white-space:nowrap">(G-SII);</FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies,
voluntarily or otherwise, which may affect Aegon&#146;s reported results, shareholders&#146; equity or regulatory capital adequacy levels. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document contains information that qualifies, or may qualify, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation
(596/2014). Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These
forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change in Aegon&#146;s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g353258dsp4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g353258dsp4.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M7L7AJST2&YF69HKEMT6GZ3;:QIOV?3 BDH[7<S !0<KEP?H'Z'K'P;L_VO\
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MF&&GGD*%64JE.A.7M%#77VLVUJ[.T>5KR9_17 N1X^&3_6:3I4[QBESN47_
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MA#_Y H /^%)?\%%?^CMM&_\ #:>$/_D"@ _X4E_P45_Z.VT;_P -IX0_^0*
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F25VVW9;MLLX [ 8]@,8J#06@ H * "@ H * "@ H * "@ H _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g353258dspp1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g353258dspp1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M33_B-G_5,_\ F1_^\0_X>5?]46_\R-_^ E'_ !!S_JH__+#_ ._0_P"(V?\
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M_DF=O^IC_P#>(O\ P\I_ZHO_ .9&_P#P$I?\0=_ZJ/\ \L/_ +],_P#B-_\
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M_,C?_@)2_P"(._\ 51_^6'_WZ1_Q&_\ ZIC_ ,R/_P!X!_P\I_ZHO_YD;_\
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M[_U4?_EA_P#?H?\ $;_^J8_\R/\ ]X!_P\I_ZHO_ .9&_P#P$H_X@[_U4?\
MY8?_ 'Z'_$;_ /JF/_,C_P#> ?\ #RG_ *HO_P"9&_\ P$H_X@[_ -5'_P"6
M'_WZ'_$;_P#JF/\ S(__ '@'_#RG_JB__F1O_P !*/\ B#O_ %4?_EA_]^A_
MQ&__ *IC_P R/_W@'_#RG_JB_P#YD;_\!*/^(._]5'_Y8?\ WZ'_ !&__JF/
M_,C_ /> ?\/*?^J+_P#F1O\ \!*/^(._]5'_ .6'_P!^A_Q&_P#ZIC_S(_\
MW@)_P\JQ_P T6_\ ,C?_ ("4_P#B#G_51_\ EA_]^EKQMNO^29M_W4?_ +Q
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M * "@ H * "@ H * "@#\9?^"B?_ "6OPO\ ]DMT3_U+/&]?T1X2?\DYC?\
ML95O_47!G\S>,W_)48#_ +%=#_U+QQ\$U^HGY&% !0 4 ,IFZV04 .%)F<]U
MZ"T$!0 4 % !0 4 % !0 AH1<-V-IF@HH$]GZ#J1B% !0 4 % !0 4 % !0
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MZ5E4?P^31U48\B?3<DIEA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M1,0K'DC&/Y5+JPA[KT<?(CV=1NZDU%[*XW>HZ'.!U/0>V?6N>>)M\"V]4:*C
MRVYGKV'HWT7ICM2P]6=24^;112MN#C&.VA(/RQ^'2NL04 % !0 4 % !0 4
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MVBW\C-^[O[MN^@5,ER?%[MN^@1U^'7T%I)Z:;= M;3:P4P"@ H * "@ H *
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ML_BZ49L_:)"#@= -K*>F0>17\[TJ+HN2M:UT?TI*,:L*<UTL_FD6JT$% !0
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M % 'XR_\%$_^2U^%_P#LENB?^I9XWK^B/"3_ ))S&_\ 8RK?^HN#/YF\9O\
MDJ,!_P!BNA_ZEXX^":_43\C&L=JD_P!WG^(=/]P$_E7/BM,/5\E^J.G!Z8FC
MZ_HSZ[^(O@>;Q7X<^#]_'XG\(Z%Y'PTMX#!KOB+1M+D/_%1ZZWFI%J5Y%)+&
M W5%;E2H^88K\YR*M&C_ &RI4JTG+%8E)TZ-6HM:5*S;IQDDEU;LEU/OL]=I
MY7:45:EA7K)+[4UUZG2:2G@Y=7^ /PH34-$\=2:-JVOZIKZ:>4U+1IEU2![@
M6N5#*21:-Q7)1<J&59O5;]FG0I035KV52;4O+6=K/L>E7C&KF^6*U[59:?\
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M'%?&XK$U,#1JWQU256=H^UK3]V,FVDTKVIKNUH?;X:E@ZE/X$DHO2+5_AO\
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M\-2P%*A*?UC"TK58XC%5)1Y:]>G-VA4@^91<?>LG=-+Y'_X8M_:8_P"B:_\
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M_P"(8<<_]"/_ ,O,O_\ FH/^&+?VF/\ HFO_ )>/@#_YJJ/^(B\&_P#0X_\
M+3'?_,P?\0PXY_Z$?_EYE_\ \U!_PQ;^TQ_T37_R\? '_P U5'_$1>#?^AQ_
MY:8[_P"9@_XAAQS_ -"/_P O,O\ _FH/^&+?VF/^B:_^7CX _P#FJH_XB+P;
M_P!#C_RTQW_S,'_$,..?^A'_ .7F7_\ S4'_  Q;^TQ_T37_ ,O'P!_\U5'_
M !$7@W_H<?\ EICO_F8/^(8<<_\ 0C_\O,O_ /FH/^&+?VF/^B:_^7CX _\
MFJH_XB+P;_T./_+3'?\ S,'_ !##CG_H1_\ EYE__P U!_PQ;^TQ_P!$U_\
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MPQ;^TQ_T37_R\? '_P U5'_$1>#?^AQ_Y:8[_P"9@_XAAQS_ -"/_P O,O\
M_FH/^&+?VF/^B:_^7CX _P#FJH_XB+P;_P!#C_RTQW_S,'_$,..?^A'_ .7F
M7_\ S4'_  Q;^TQ_T37_ ,O'P!_\U5'_ !$7@W_H<?\ EICO_F8/^(8<<_\
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M .:JC_B(O!O_ $./_+3'?_,P?\0PXY_Z$?\ Y>9?_P#-0?\ #%O[3'_1-?\
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M_P#+S+__ )J#_ABW]I@?\TUZ?]3CX [?]S51_P 1%X-7_,X_\M,=_P#,P?\
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MU='_ !$?@O\ Z'/_ ):8[_YE'_Q#/CG_ *$?_EYE_P#\U!_PQ9^TW_T30_\
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M_P#!0S_HG/A?_P &WP]_^:ZCZAX6?]#Q_P#@G-/_ )@#ZUXM?]".'_@_*_\
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M /FX/^$A_P""AG_1.?"__@V^'O\ \UU'U#PL_P"AX_\ P3FG_P P!]:\6O\
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MKJ/J'A9_T/'_ ."<T_\ F /K7BU_T(X?^#\K_P#FX/\ A(?^"AG_ $3GPO\
M^#;X>_\ S74?4/"S_H>/_P $YI_\P!]:\6O^A'#_ ,'Y7_\ -P?\)#_P4,_Z
M)SX7_P#!M\/?_FNH^H>%G_0\?_@G-/\ Y@#ZUXM?]".'_@_*_P#YN#_A(?\
M@H9_T3GPO_X-OA[_ /-=1]0\+/\ H>/_ ,$YI_\ , ?6O%K_ *$</_!^5_\
MS<'_  D/_!0S_HG/A?\ \&WP]_\ FNH^H>%G_0\?_@G-/_F /K7BU_T(X?\
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M%B9^VRY\F']K%5I6IXV4WRT^9VA&4G;W8MV1]ZU^8'ZT% !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
/% !0 4 % !0 4 % '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
